Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

Market Cap	12.23B
Revenue (ttm)	3.74B
Net Income (ttm)	534.00M
Shares Out	431.05M
EPS (ttm)	1.24
PE Ratio	22.86
Forward PE	18.73
Dividend	0.62 (2.18%)
Ex-Dividend Date	Jul 26, 2024

Volume	6,295,249
Average Volume	4,801,116
Open	28.38
Previous Close	28.38
Day's Range	27.72 - 28.47
52-Week Range	21.33 - 31.46
Beta	0.38
RSI	54.53
Earnings Date	Aug 29, 2025

About SHA:600993

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of Chinese and Western medicines primarily in China. The company provides functional cosmetics, such as eye care, eye daily necessities, facial and body cleaning, and care products; functional care products include infant paper, infant skin care, feminine products, etc.; functional foods, including moisturizing the intestines, promoting digestion, and nourishing the kidneys. It also offers foundation and dietary supplements; medical ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1582
• Employees: 2,654
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600993

Financial Performance

In 2024, SHA:600993's revenue was 3.73 billion, an increase of 18.85% compared to the previous year's 3.14 billion. Earnings were 528.09 million, an increase of 19.14%.